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Leading Edge
Highlights of Current Research
Moderating calorie intake during pregnancy
won’t harm the fetus
Although obesity in pregnancy continues to be
associated with a host of health problems, many
clinicians have been reluctant to place non-diabetic,
obese pregnant women on a monitored, calorieappropriate nutritional regimen for fear of limiting
fetal growth or even precipitating low birthweight
or starvation ketosis.
A new study led by Yvonne S.Thornton,
M.D., M.P.H., clinical professor of obstetrics
and gynecology, reports that obese women can
be placed on a healthy, well-balanced, monitored
nutritional program during pregnancy without
adversely affecting the fetus.
A total of 257 patients were enrolled in the study
in which patients were given either conventional
prenatal dietary management or were prescribed
a balanced nutritional regimen and were asked to
record in a diary all of the foods eaten during each
day. The results showed that pregnant women who
adhered to the balanced regimen and recorded
their food intake were less likely to develop
gestational hypertension, had less weight gain
during pregnancy, and were quicker to return to
their prenatal weight within six weeks of delivery.
Patients gaining 15 pounds or more during their
pregnancy showed statistically significant differences
between the groups for eight variables.
The researchers concluded that obstetricians
can safely place their obese patients on a healthy,
monitored nutrition program during pregnancy
without fear of compromising the health of either
the mother or the baby.

“Perinatal Outcomes in Nutritionally Monitored Obese Pregnant
Women,” The Journal of the National Medical Association, June 2009.
Online at http://www.nmanet.org/index.php/Publications_Sub/jnma

Researchers examine quality of life after
cancer
Cancer treatment has become so advanced in recent
years that a diagnosis no longer spells certain death as
it once did. In fact, many cancer patients, after undergoing successful treatment, readily return to their jobs
and their lives, apparently restored to the good health
and quality of life they enjoyed before they became
ill. But not every cancer patient can look forward to
such a rosy outcome. Have we become unrealistic in
expectations of cancer treatment?
A recent study led by Frank Baker, Ph.D., School
of Health Sciences and Practice, examined quality of
life issues for cancer patients. The team obtained data
from 16,850 individuals aged 65 years and older who
were enrolled in Medicare managed care plans and
who had completed a quality-of-life questionnaire in
1998 and again in 2000. For those previously diagnosed
with cancer, there was no evidence that their quality of
life returned to normal levels (i.e, before onset of the
disease) after two years. Quality of life declined
for all participants over the two years studied as
age increased. Those who previously had cancer had
poorer quality of life than those without cancer at
both times. However, the rate that quality of life
worsened was the same for both groups. The change
in quality of life was also greater for physical health as
compared to mental health.
The researchers advise that physicians treating elderly
individuals with cancer should be aware that both
(continued on page 32)
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On the Cover
For the first time, Chironian’s personality profile features not one but two high-powered individuals who contribute tirelessly to the
mission of the College: Leonard J. Newman, M.D., ’70, professor and chairman of the Department of Pediatrics, at right, and Michael H.
Gewitz, M.D., professor and department vice chairman and executive director and physician in chief at Maria Fareri Children’s Hospital/
Westchester Medical Center. Both are pediatricians with busy practices (although none of the giggling preschoolers who posed for our
cover shot in the lobby of the Children’s Hospital are patients of the good doctors). Colleagues say they make a remarkable team, working
together to manage the academic and clinical needs of the Department of Pediatrics, both at the College and at the Children’s Hospital.
Special thanks to Wendy Masserman, director of For Kids Only in Briarcliff Manor, N.Y., her staff and those irrepressible kids.
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Collaborators, Educators, Administrators—
and They Even Do Translational Research
Together and individually, Jan Geliebter, Ph.D., and Raj Tiwari, Ph.D.,
are investigating malignancies of the breast and prostate,
and training a new generation of scientists—all without missing a beat.
By Dan Hurley

T

he wiry, animated Jan Geliebter, Ph.D., stands, gestures at his
jottings on a white board, and begins talking a mile a minute
while his colleague, the considerably more relaxed Raj Tiwari,
Ph.D., eases back in his chair, his hands clasped behind his head. You’d
never know it, but they are discussing their educational backgrounds.
“I’m from Brooklyn; you got a problem with that, we’ll take it outside,” jokes Dr. Geliebter. “I got my Ph.D. from Calcutta University,”
Dr. Tiwari puts in. “I speak too quickly, he speaks too slowly,” quips
Dr. Geliebter. “I have to compensate.”
Different as they are, the two men have formed a close partnership
on their research in preventing, diagnosing and treating cancers,
particularly of the thyroid, prostate and breast. They also share a
passion for teaching and administration, and with a cadre of students,
fellows, post-docs and residents all playing a role in their sizable body
of research, they like to say they are training the next generation.
Both are professors in the Department of Microbiology and
Immunology, and each has administrative responsibilities—Geliebter
as course director and Tiwari as graduate program director. Both
men have appointments in the Department of Otolaryngology,
where Dr. Geliebter is also the resident research coordinator.
“They work so well together,” says Ira Schwartz, Ph.D., professor
and chairman of the Department of Microbiology and Immunology.
“They are a perfect complement. And at a personal level, they’re
very close friends. It’s a very prolific partnership that they’ve
developed.”
Some of their most productive work has been investigating a
potent cancer-preventing compound found in all cruciferous
vegetables called 3,3’-Diindolymethane, or DIM, which Dr. Tiwari
has studied since 1994. A 2005 paper they co-authored with a
team of researchers and clinicians, some of whom practice at
The New York Eye and Ear Infirmary (NYEEI), a College affiliate
in Manhattan, showed that DIM is a potent anti-proliferative agent
against thyroid cancer, and inhibits the growth of primary goiter
cells by 70 percent.
Dr. Tiwari is principal investigator leading a team of clinicians and
basic scientists on an NIH-funded R01 grant to study the basic
biology of DIM, as well as its clinical efficacy in thyroid proliferative
diseases. In addition, he and Dr. Geliebter are working with principal investigator Stimson Schantz, M.D., professor of otolaryngology,
who is recruiting patients for a clinical trial of DIM. The study will
examine patients with goiter who will undergo surgery, to see if DIM
improves their outcomes versus a placebo. Drs. Tiwari and Schantz
have a long and successful history of collaborating since their days
together at Memorial Sloan-Kettering Cancer Center.

Left:The research teams of Raj Tiwari, Ph.D., seated center, and Jan Geliebter,
Ph.D., standing center and at right, each have a distinct focus, but their paths
cross often in the course of their collaborations. Surrounding the two lead
investigators are, clockwise from left: Ismael Reyes, Ph.D., post-doctoral
fellow; Scott Nowicki, M.D./Ph.D. student; Josh Bedwell, M.D., otolaryngology
resident; Robert Suriano, Ph.D. ’07, post-doctoral fellow; visiting exchange
student Parthajit Mukharjee; Andrea George, Ph.D. candidate; Arulkumaran
Shanmugam, Ph.D., post-doctoral fellow; and Shilpi Rajoria, Ph.D. candidate.
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“What is found in cancer cells but
not in normal cells can be used
as a biomarker for diagnosis or
prognosis of cancer or as a target
for therapeutic intervention.”
– Jan Geliebter, Ph.D.

Nothing lost in translation
At its root, their plan is to conduct research that translates directly
into improved patient care, whether through prevention, diagnosis or
treatment. The two researchers view their thyroid investigations as
true translational research, a collaboration among clinicians who fully
understand the disease and the concerns of the patient, and the basic
scientists who carry out the bench studies to address the issues. As
Dr. Tiwari points out, “If research cannot be translated, it may not have
value in a medical setting.”
Both Geliebter’s and Tiwari’s groups are taking an integrated genomics
approach to thyroid cancer, “where we are looking at the sum total
of all the molecules in normal and cancerous thyroid cells and asking
what is different between them,” explains Dr. Geliebter. “What is found
in cancer cells but not in normal cells can be used as a biomarker
for diagnosis or prognosis of cancer or as a target for therapeutic
intervention.”
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In Dr. Geliebter’s lab, the team uses microarray technology to identify
molecular differences between normal and cancerous thyroid tissue for
the discovery of molecular biomarkers and therapeutic targets such as
ALOX-5. Down at New York Eye and Ear, otolaryngology residents are
studying genes identified as potential molecular biomarkers. A skilled
team of pathologists and technicians provide clinical samples for the
research. All are overseen by Dr. Schantz, who provides necessary
clinical input (see sidebar on page 6).
DIM is just one of many compounds being investigated by the researchers. The College now owns the patent on a novel anti-cancer agent
called C 1748, developed by Dr. Tiwari in collaboration with researchers
from as far away as Gdansk, Poland. Building on compounds developed
in Poland in the 1970s, Dr. Tiwari sought one that would exhibit more
potent effects on tumors with less systemic toxicity. The most active
and least toxic proved to be the substance C-1748, also known as
nitroacridine. To pave the way for a human trial targeting prostate
cancer, Dr. Tiwari’s group published a 2006 paper in Life Sciences
showing that, in sharp contrast to most chemotherapeutic agents,
nitroacridine produced only minimal and transient side effects.

New treatments on the horizon
“There is currently no approved chemotherapy for prostate cancer,”
Dr. Tiwari says. “We have finished our toxicology and pre-clinical work,
and are looking for partners to initiate a clinical trial.”
On the basic biology front, Dr. Tiwari has recently discovered progenitor
stem cells that promote the vascularization of breast cancer cells. As
senior author of a paper published last August in the journal Cancer
Research, he and post-doctoral fellow Robert Suriano, Ph.D. ’07,

stress in the prostate, resulting in genetic damage and inflammation.
Together the effects are synergistic, multiplying the chances for cancer.
“The prostate in a young rat on a high fat diet has the same level of
oxidative stress levels as a prostate from a much older rat on a low
fat diet. Think of the high fat diet we eat in the U.S., and there is no
wonder that prostate cancer rates have skyrocketed,” Dr. Geliebter says.

Over-expression of ALOX-5
Enhanced expression of the gene ALOX-5 increases invasiveness of thyroid cancer
cells.The panel on the right shows increased invasion of thyroid cancer cells (magenta)
across a filter, digesting tissue matrix and migrating through holes (black spots on
filter), due to over-expression of ALOX-5.The panel on the left shows thyroid cancer
cells with a low level of ALOX expression. ALOX-5 over-expression induces the cancer
cells to produce enzymes that degrade tissues and allow cells to spread. Images
courtesy of Jan Geliebter, Ph.D.

described bone marrow-derived endothelial progenitor cells that are
mobilized by the hormone 17ß-estradiol.
“We are very excited about the findings,” he says. “We are using adult
stem cells that are important in making new blood vessels, and targeting
those new blood vessels for therapy in both breast and thyroid cancer.”
Dr. Tiwari is also hard at work on an experimental vaccine that would
boost the immune system’s ability to recognize and destroy cancer cells.

“We are not only academicians—
we feel we should leave a legacy
of our vision with the younger
generation.”
– Raj Tiwari, Ph.D.

As important as research is to Drs. Tiwari and Geliebter, their
commitment to their students is evident to all who know them.
“They’re very nurturing to medical students and residents,” says
Steven D. Schaefer, M.D., professor and chairman of the Department
of Otolaryngology.
“We have a lifelong, personal commitment to education,” Dr.
Geliebter says. “Raj has to make sure that all 40 postgraduates in
microbiology and immunology are doing productive work, that
they’re moving along, that their projects will take them to a thesis.”
“Our vision for translational research in cancer, as well as our teaching
philosophies, match each other’s very well,” Dr. Tiwari says. “We are
not only academicians—we feel we should leave a legacy of our
vision with the younger generation.”

Separate paths, similar values
The understanding and enthusiasm that Drs. Tiwari and Geliebter
share for each other’s work can be traced, at least in part, to their
arrival at the College within a month of each other, in 1996. Dr.
Geliebter received his bachelor’s degree from Hebrew University
in Jerusalem, followed by a doctorate from SUNY Downstate in
Brooklyn. He did a post-doc at Albert Einstein College of Medicine
and was on the faculty at Rockefeller University and at Einstein.
After obtaining his Ph.D. from Calcutta University, Dr.Tiwari completed
postdoctoral training at the University of Toronto’s department of
immunology. He then went to Memorial Sloan-Kettering, where he
served on the molecular biology faculty from 1989 until 1992. From
there he moved over to the faculty at Cornell University, where he

“We wondered why the immune system doesn’t always recognize a
cancer as foreign,” he says. “We felt it becomes too tolerant. So we
looked for a way to boost the immune system.” His lab is finding
synthetic peptides that mimic the cancer, different enough from the
standard tumor cells to stimulate an immune reaction, but similar enough
to result in the immune system also attacking the cancer. This is called
cross-reactivity between the peptide mimic and the native antigen.
“The animal studies are very encouraging. We are collaborating with
Abraham Mittelman [M.D., clinical associate professor of medicine,] for
patient-based clinical research,” says Dr. Tiwari, who co-authored a review
article with Dr. Geliebter earlier this year on the fast-growing field of
cancer immunotherapy. He adds, “We have licensed this to a company
that is funding the vaccine work.”
Dr. Geliebter’s laboratory studies prostate and thyroid cancer on the
molecular level. In particular, his group is interested in the etiology of the
diseases, as well as molecular biomarkers for the diagnosis and prognosis
of these cancers. For example, his laboratory is studying the effects of
diet, aging, environmental factors and oxidative stress on the initiation
and promotion of prostate cancer. Brother and sister post-docs Ismael
Reyes, Ph.D., and Niradiz Reyes-Ramos, Ph.D. ’03, have found that a high
fat diet and the aging process each independently increase oxidative

Invading Stem Cells
In this pair of slides, stem cells
invade goiter nodules to initiate
formation of new blood vessels. Slide
at top shows normal cells. At right,
arrows point to new blood vessels
being formed in response to the
tumor. Merged yellow and green
markings are the stem cells from
bone marrow that are initiating new
blood vessels.These are potential
targets of therapy to prevent
formation of new blood vessels that
help the cancer to grow. Images
courtesy of Raj Tiwari, Ph.D.
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remained until coming to the College.
Despite their different starting points,
“we quickly realized we shared an
interest in the molecular basis and
chemoprevention of cancer,” Dr.
Geliebter says. “You can’t be an island
in science. And it’s easier to get funding
when there’s more than one researcher
involved. In Brooklyn we call it more
bang for the buck.”
One more thing the two researchers
share: enormous respect and admiration for their colleagues. With little
prompting, they will list more than
25 colleagues, including post-docs,
M.D./Ph.D. and grad students, otolaryngology residents, physician assistants,
pathologists and nurse practitioners
who contribute to the work. But they
reserve a special regard for the two
department chairs who have opened
so many doors.
“It would be very tough without a
chairman who supports this kind of
collaborative environment,” says Dr.
Tiwari. “The Department of Otolaryngology under Steve Schaeffer has
shown a remarkable commitment to
research. They respect research and
the people who do it.” p

Making Good on the Promise
of Intramural Collaboration

I

In a paper published in 2006 in the
Journal of Proteome Research, Drs.
Tiwari, Schaefer, Geliebter, Schantz and
others described how they combed
through thousands of potential
biomarkers. Using proteomic techniques, they settled on a constellation
of 63 that together correctly identified
a non-cancerous sample that had
previously been labeled suspicious.

ntramural collaboration with
clinicians in the Department of
Otolaryngology has been essential
to the thyroid cancer research of Dr.
Geliebter and Dr. Tiwari.
Steven D. Schaefer, M.D., professor
and chairman of the Department of
Otolaryngology, collaborated with the
researchers on the pre-clinical DIM
paper (see main story), and recently
decided to grant them intramural
funding from his department for two
new studies of thyroid cancer—one
involving gene expression, the other
immune markers.

“There is a lot of virtue in trying to find
markers in the overall genomic and
proteomic profile,” Dr. Tiwari says.

“Their studies intersect with the interests
of this department, so it was a good fit,”
Dr. Schaefer says. “They’re both good
scientists, producing results all the time,
and they’re a pleasure to work with.”
Their research into molecular markers
of papillary thyroid cancer began when
Stimson Schantz, M.D., Dr. Schaefer’s
colleague at The New York Eye and
Ear Infirmary (NYEEI), explained to
them that in 20 percent of biopsy
samples, it’s impossible to tell
whether or not cancer is
present, and so surgery to
remove the whole gland
must be undertaken as a
precaution.
“Remember the old Star
Trek and the ‘prime
directive?’” Dr. Geliebter
says. “We were given a
prime directive by Dr.
Schantz: find a molecular
marker for thyroid cancer.”

The collaboration between clinicians at
the NYEEI and the College is wholeheartedly endorsed by the chairman of
the Department of Microbiology and
Immunology, Ira Schwartz, Ph.D.
“The most important aspect of
medical research today is translating
basic scientific findings into clinical
practice,” Dr. Schwartz says. “As a
basic science department, we need to
collaborate with clinical departments to
bring research from bench to bedside.
Fortunately we’ve found a very willing
partner in Dr. Schaefer and his group at
New York Eye and Ear. It’s developed
into a wonderful collaboration.”
Drs. Geliebter and Tiwari credit Dr.
Schwartz with fostering an atmosphere
where collaboration is valued, and
shower praise on the clinicians at
NYEEI.
“I have to emphasize how helpful the
people are at New York Eye and Ear—
not just the attending physicians and
residents, but everyone, from physician
assistants and nurse practitioners to pathologists,” says Dr. Geliebter. “It’s rare
to have that kind of cooperation. And
they recruit faculty who are interested in
research. It’s really an ideal situation.”
— Dan Hurley

When basic scientists and clinicians come together on a
research endeavor, the goal is to apply discoveries generated through basic scientific inquiry to the treatment
or prevention of disease. Nobody knows this better than
Steven D. Schaefer, M.D., professor and chairman of the
Department of Otolaryngology and head of the residency program at The New York Eye and Ear Infirmary.
A clinical researcher, he not only collaborates with bench
scientists, he also supports their work with funding from
his own department.
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ZHONGTAO ZHANG, PH.D.,

Takes on
Parkinson’s
Disease
A biochemist pinpoints
dopamine oxidation as the
cause for brain cell death
and depletion of the
neurotransmitter that
characterizes the disease’s
early stages.
By Marjorie Roberts

B

efore the actor Michael J. Fox gave a face and a poignant
backstory to Parkinson’s disease (PD), research into
the motor system disorder was as inconspicuous as the
neurodegenerative illness in its earliest stage—the years before
the telltale symptoms of tremor, rigid limbs and slow movement
begin to appear. Thanks to the actor’s foundation for Parkinson’s
research and his passion to maneuver PD to the front burner,
the disease has caught the fascination of a new breed of scientists
who are eager to combine its long history of significant discoveries and disappointing outcomes with the promises of molecular
biology and stem cell therapy to find a cause and cure.
Zhongtao Zhang, Ph.D., an assistant professor of biochemistry
and molecular biology, is a basic science pioneer who stands by
the conviction that to understand the enigma that is Parkinson’s
disease depends on finding out why the dopamine-producing
brain cells (neurons) are disappearing from the area of the brain
known as the substantia nigra. Dopamine is a neurotransmitter
that helps to relay messages that control body movement. As
the chemical is depleted, the lives of PD sufferers slowly diminish
as the chronic illness progresses toward a debilitated end. In
some 30 percent of cases, there is mental deterioration as well.

After Zhongtao Zhang received his Ph.D. in biochemistry from Purdue
University, he did cancer research as a post-doc at Yale and NYU.
Then he decided to study the other end of the cell growth process—
neurodegeneration—and trained his sights on Parkinson’s disease.
CHIRONIAN
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In his quest to slow down the neuronal degeneration
that is the hallmark of Parkinson’s disease, Dr. Zhang
focuses on proteins already linked to the movement
disorder. At left is a graphic of the enzyme quinone
reductase 2 in complex with dopamine (red spheres),
which he believes is key to retarding the process. At
right is the enzyme DJ-1, a key protein against oxidative
stress that can lead to Parkinson’s when it undergoes
certain genetic mutations. Images courtesy of Zhongtao
Zhang, Ph.D.

By the time a patient’s symptoms appear,”
Dr. Zhang advises, “70 percent of the neurons
delivering dopamine have died. What we have
to do is figure out how the degeneration
starts and then slow it down enough for
patients to live to the age of 90.” Slightly
more than half of the 50,000 new cases
reported annually are men, and the average
age of PD onset is 60. A small percentage
of cases are clearly inherited, but in most
instances, they are not. The National
Parkinson’s Foundation estimates that Parkinson’s affects one million Americans, ranking
it second only to Alzheimer’s disease in
incidence of neurological disorders. Dr. Zhang
does not think the correlation is coincidental.

Partners in crime
“I believe Parkinson’s and Alzheimer’s are
related. When you find a solution to one
you will have solved the other,” he says flatly.
He dismisses some purported causes that
have held sway from time to time, such as
aluminum cookware, use of pesticides and
abstaining from coffee.
If his research commitment over the last
decade is any indication, Dr. Zhang is making
headway. Before the term of his first NIH
grant for $1,443,000, “Structure/Function
Studies of quinone reductase 2,” ended in
March, Dr. Zhang had applied for another
NIH award. The first study confirmed his
hypothesis that research in PD must begin
with controlling the dopamine oxidation
that is killing the neurons. “My laboratory
discovered that an old enzyme, quinone
reductase 2, is regulating dopamine oxidation.
Many pieces are still missing, but if we can
figure out how to slow the process down, we
can eventually retard the progression of the
disease,” he says. Assisting him in the project
were Yue Fu, a Ph.D. student who graduated
in 2008, and a post-doctoral fellow, Leonid
Buryanovskyy, Ph.D., who is still working in
his laboratory.
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“Dopamine-producing neurons preferentially
get degenerated in Parkinson’s disease,” Dr.
Zhang explains. “Perhaps it’s because these
neurons contain the most dopamine. As a
chemist, I took a close look at the chemical properties of dopamine and its related
neuron transmitters—norepinephrine and
epinephrine. These chemicals are especially
sensitive to oxidation, and the oxidation
products are very reactive and toxic. I reasoned that our body must have many ways
to defend against the toxins and failure of
any of the defense pathways will result in the
early onset of neurodegenerative disorders.”
The new grant would support further
investigation of three of eight Parkinsonrelated proteins that have been discovered
by other laboratories over the last decade.
“These are important proteins that are
defending against dopamine oxidation, but
we don’t know exactly how they do it,” he
says. Dr. Zhang has elected to study alphasynuclein, a major component of Lewy
bodies, which are abnormal aggregates of
protein that develop inside neurons and
eventually displace other components of the
cell. He considers alpha-synuclein a major
contributing factor to neurodegradation.
Critical proteins
His second target is called DJ-1; its purpose
is undetermined, though it is considered essential to the human body. The third

protein is Parkin, also known as ubiquiton
ligase, which he calls “the garbage disposal
responsible for the degradation of junk proteins
in the cell.” He is trying to determine what
type of damaged proteins Parkin is seeking.
Basic scientists often disparage clinical concerns
in favor of pure science in their research, but
Dr. Zhang is not one of them: “I am going
to stick with Parkinson’s because I believe
age-related diseases have the most impact
on society. They are expensive to treat, both
economically and socially.” His initial research
interest was cancer, and he accepted fellowships to study receptor proteins with Dr.
Joseph Schlessinger, first at New York University Medical Center and later at Yale. Dr. Zhang
began his long road to a Ph.D. with an undergraduate degree in chemistry and education
—“I was trained to be a chemistry teacher,”
he says— from a university in Shanghai, China,
followed by a master’s degree in organic
chemistry from Beijing Medical University.
He graduated in 1989, the same year he
decided to come to America for his Ph.D.
In 1994 he received his doctoral degree in
biochemistry from Purdue University, where
he had started researching protein tyrosine
phosphatase—fascinated, he says, by cellular
signal transduction pathways, especially protein
phosphorylation and dephosphorylation. In
2002, after the post-docs were completed, he
accepted an assistant professor appointment
at New York Medical College.

“I believe Parkinson’s and Alzheimer’s are
related. When you find a solution to one
you will have solved the other.”
– Zhongtao Zhang, Ph.D.

“Many pieces are still missing, but if we can
figure out how to slow the process down,
we can eventually retard the progression of
the disease.”				
– Zhongtao Zhang, Ph.D.
Opposing forces
Dr. Zhang’s background has given him a leg up
on Parkinson’s disease. “Neurodegeneration
and cancer are at the opposite ends of the cell
growth process. Neurodegeneration is caused by
early cell death, whereas cancer is the result of
uncontrolled cell growth,” he explains. “It is a fact
that PD patients have a significantly reduced risk
of several cancers, including lung and prostate.
However, they also have a slight increase in risk
for brain, melanoma and breast cancers. The
question is, if we find something to prevent PD
and AD, will it increase the risk of cancer? At this
point I just don’t know the answer.”

disease, there are therapies that relieve
symptoms—at least for a while, until they
stop working. Levodopa (L-dopa) was
discovered 40 years ago and remains the
gold standard of treatment—but at a price.
It is the precursor of dopamine, taken up by
nerve cells to make dopamine and replenish
the brain’s dwindling supply. But it does nothing
to halt the continuing death of the brain’s
remaining neurons. What’s worse, Dr. Zhang
believes L-dopa may even be accelerating
their demise. In any case, in five to ten years
the neurons are no longer responsive to
treatment.

While there still is no drug that can cure, delay,
prevent or reverse the course of Parkinson’s

Periodically, another drug or treatment
emerges in the Parkinson camp and causes

some excitement. Dopamine agonists like
Mirapex and Requip, which can substitute for
dopamine quite effectively, are now standard
treatment. But eventually they stop working, too.
Alleviate symptoms
Gaining in popularity is a surgical procedure
called deep brain stimulation (DBS) that is
remarkably effective at alleviating the tremors
and flailing movements (dyskinesia) that steadily
worsen as the dopamine fades away.
As for the stem cell approach touted by
Michael J. Fox, Dr. Zhang does not have
much confidence in it as a cure, although his
open mind dictates that he go wherever his
experiments take him.
“People, especially scientists, make everything
very complicated and they often miss the
obvious, the simple things.” he says. “My goal is
to find something cheap enough for PD patients
to use until the day they die.” Certainly, he
asserts, there will be a need. “Parkinson’s and
Alzheimer’s diseases go hand in hand with aging,
and getting them may be inevitable if you live
long enough.”p
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Protecting the
Fragile Baby Brain
Neonatologist and researcher Praveen Ballabh, M.D., is
discovering possibilities for preventing brain hemorrhages
in vulnerable preterm infants.
By Cynthia A. Read

M

edicine’s ability to save even the
tiniest premature babies—those
weighing less than 1,000 grams
(about 2.2 pounds) and born as early as 23
weeks—is a scientific miracle. What was once
almost unimaginable is the fact that now 85
to 90 percent of these infants survive. But
the miracle often comes at a high price.
Fragile blood vessels in the immature brain
frequently rupture with damage from the
hemorrhage causing devastating complications:
hydrocephalus, cerebral palsy and mental
retardation. While parents of these tiny,
vulnerable infants may have prayed for their
children to survive, they probably did not
realize that it may come at the cost of brain
hemorrhage, the most common neurological
problem in premature infants.
Praveen Ballabh, M.D., associate professor of
pediatrics in the Division of Newborn Medicine,
wants to improve the odds for these micropremies. Since coming to New York Medical
College in 2001, he has been researching the
causes of germinal matrix hemorrhage (GMH),
which occurs in up to 20 percent of preterm
infants born at less than 1,500 grams. With a
steely determination belied by his gentle eyes
and lilting voice, he is tracking ways to prevent
GMH and to mitigate its dreadful effects.

At right: As principal investigator on NIH-funded studies of the delicate mechanisms of the newborn brain,
Dr. Ballabh (center) relies on his team. From left they
are: Caroline Chua, M.D., neonatal-perinatal fellow;
Govindaiah Vinukonda, Ph.D., instructor of pediatrics;
Muhammad T. Zia, M.D., assistant professor of pediatrics;
Krishna Dummula, M.D., neonatal-perinatal fellow; and
Furong Hu, research associate.

Neonatologist, researcher
Dr. Ballabh was trained as a general
pediatrician at the Institute of Medical Sciences,
Varanasi, India. After coming to the United
States to study pediatric critical care, he
decided to specialize in neonatology. Although,
he observed, “In general, neonatologists are
more focused on clinical issues than on
research,” he thought he could be both
creative and productive in this field. During a
neonatal fellowship at The New York Presbyterian Hospital-Weill Cornell Medical Center, his
first studies focused on chronic lung disease in
premature infants. It quickly became obvious,
however, that although you could fix the lungs
of a newborn, the brain was another matter.
“The baby might survive,” he comments, “but at
what cost, if the parents were left with a child
seriously damaged by a brain hemorrhage?”
Usually occurring in the first 72 hours after
birth and primarily in extremely premature
newborns, brain hemorrhages affect nearly
12,000 newborns each year in the United
States. They originate in the germinal matrix, a
temporary structure around the cavity of the
brain in all developing fetuses. Neurons
and glial cells originate in the germinal matrix
and migrate out to form the cerebral cortex
of the brain. Rich in blood vessels, the
germinal matrix slowly regresses in the baby’s
maturing brain and almost disappears by
36 weeks gestational age. But if the baby is

researcher now at the University of Rochester.
He began to explore why the blood vessels in
the germinal matrix are so fragile and porous.
Their research focused on vascular density—
the germinal matrix has two to three times
more vasculature than the cerebral cortex—
and on the cellular structure of the germinal
matrix blood vessel. Papers were published in
Neurobiology of Disease and Pediatric Research.

The germinal matrix (GM) is made up of premature neurons and glial cells (green), enriched with
blood vessels (red). Nuclei of neuronal and glial
precursors are stained blue. Unlike blood vessels
in other parts of the brain, GM vasculature is
especially vulnerable to hemorrhage. When the
hemorrhage is substantial, blood leaks into the ventricle (appearing here as a black cavity), resulting in
intraventricular hemorrhage. Confocal microscopy
showing brain section of a 24-week premature infant
courtesy of Praveen Ballabh, M.D.

born prematurely, the germinal matrix is still a
looming presence—and it bleeds with alarming
ease. If the hemorrhage is substantial, it spreads
into the brain’s ventricles; doctors call this an
intraventricular hemorrhage (IVH).
Group effort
Dr. Ballabh collaborated with Maiken
Nedergaard, M.D., D.M. Sc., a former faculty

With NIH grant support, Dr. Ballabh
re-focused his attention on angiogenesis, the
process by which new blood vessels are
created. Angiogenesis is primarily influenced
by two molecules, vascular endothelial growth
factor (VEGF) and angiopoietin-2, both of which
cause rapid proliferation of blood vessels in
humans and in animal models. He and his team
evaluated angiogenesis in postmortem brain
tissue, both human and animal, and observed
active vessel growth in three comparative
models. They also found that VEGF, angiopoietin-2, and endothelial cell proliferation were
consistently higher in the germinal matrix
relative to the rest of the brain.
If angiogenesis in the germinal matrix could be
slowed or halted close to the time of preterm
delivery, Dr. Ballabh hypothesized, perhaps
there would be fewer new blood vessels
susceptible to the stress of birth and adjusting
to life outside the uterus and, consequently,
fewer hemorrhages. Various drugs have been
shown to reduce angiogenesis in tumors,
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“The research would be impossible
without teamwork. My team members
have contributed as much as I have.”
– Praveen Ballabh, M.D.
					

pharmacy graduate from China, is in charge
of the premature rabbit pups. Dr. Ballabh
emphasizes, “The research would be impossible without teamwork. My team members
have contributed as much as I have.”
Dr. Ballabh received $187,625 from Pfizer to
study the postnatal use of celecoxib in their
rabbit model. Giving this drug to newborn
rabbit pups appears to decrease neuronal
death after the brain bleeds, so he is investigating whether this will also reduce the
incidence of cerebral palsy. While these studies
are ongoing, Dr. Ballabh is seeking another
NIH grant to continue his research.
A promising alternative to the celecoxib
approach is the use of apocyanin, a NADPH
oxidase inhibitor. Supported by an intramural
grant awarded to Dr. Zia, Dr. Ballabh and his
team collaborated with colleagues in the
departments of Physiology and Pediatrics on a
paper for Stroke (now in press) showing that
apocyanin reduces cell death in premature
rabbit pups with brain hemorrhage. Another
intramural grant, this one awarded to Dr.
Vinukonda, will enable the group to explore
protective interventions after IVH.

including celecoxib, a selective COX-2 inhibitor
primarily used to treat arthritis, menstrual
pain and certain tumors. So Dr. Ballabh and
his team tested prenatal treatment of rabbits
with celecoxib and with a VEGF inhibitor,
ZD6474. What they found is that it not
only decreased VEGF, angiopoietin-2, and
endothelial cell proliferation, it also decreased
the incidence of a moderate or severe GMH
by half—from 90 percent to 45 percent. Their
research was published in Nature Medicine
in 2007, with a follow up study published in
2008 in the Journal of Neuroscience.
An important question, Dr. Ballabh points
out, is whether it might be risky to stop the
formation of new blood vessels in the baby
brain. But the pharmaceutical intervention he
has been investigating must be administered
within three days before delivery, shrinking
the window of risk. Moreover, a small study
by another group has already safely used
celecoxib to slow preterm labor in pregnant
women. His third point of fact is that once an
infant is born—whether at 24 or 30 weeks—
the increased oxygen in its system upon
exposure to room air naturally suppresses
angiogenesis. For a neonatologist who has
seen his share of grieving parents, he hopes
to discover that the treatment is worth
the risk.

12

Spring/Summer 2009

Pursuing prevention
While continuing to pursue this line of
investigation, with the eventual goal of a clinical
trial testing the use of celecoxib in pregnant
women as a preventive, Dr. Ballabh and his
group are investigating other possibilities for
preventing or minimizing brain damage after
the development of GMH and IVH. In working
with rabbit pups, he believes they have hit
upon an excellent animal model for IVH. If he
induces hemorrhage in these preterm rabbit
pups at birth, by the end of two weeks 25
percent will have motor problems that mimic
cerebral palsy, and 44 percent will have hydrocephalus. Their research, called “revolutionary”
by Edmund F. LaGamma, M.D. ’76, director of the
Division of Newborn Medicine at the College
and the Regional Neonatal Center at the hospital,
is under review for publication.
There are five members on the team, each
with expertise in a specialized area. Neonatologist Muhammed Tahir Zia, M.D., assistant
professor of pediatrics, is particularly interested
in oxidative stress, while genetics and the
gene detection of molecules are the focus of
Govindaiah Vinukonda, Ph.D., an instructor in
pediatrics. Two neonatology fellows, Krishna
Dummula, M.D., and Caroline Chua, M.D., who
is skilled in using head ultrasound to diagnose
IVH, are emerging neuroscientists. Furong Hu, a

Support from the Division of Newborn
Medicine, along with a two-year, $100,000
grant from Maria Fareri Children’s Hospital
Foundation, is financing the research of cell
surface proteins (integrins) in the germinal
matrix and in the brain tissue in other parts
of the brain as well. Because integrin beta-2 is
critical to embryonic angiogenesis, inhibiting
its expression might be a way to suppress the
growth of blood vessels, thus reducing the
chance of GMH.
Holding a vision
Like all dedicated researchers, Dr. Ballabh
must make considerable sacrifices in his
personal life to pursue his research goals. He
rotates into clinical service at the children’s
hospital for two to three months a year and
is frequently on call. He is always teaching,
whether at the conferences, in the hospital,
or with fellows in his lab, whom he says he
drives very hard.
His objective in everything he does is “to
make life better for the babies.” By hunting
down better ways to protect their vulnerable
brains from bleeding, he holds the vision of a
day when he will never again have to “wipe
away the tears of a mother after I’ve told
her that her baby’s chances are slim
because he has a major hemorrhage all
through his brain.”p

SPLIT
SPLIT PERSONALITY:
Leonard J. Newman, M.D. ’70, and Michael H. Gewitz, M.D.
No schizophrenia here...
it’s all about two pediatricians
who have made taking care
of children their life’s work.
By Marjorie Roberts

L

Leonard J. Newman, M.D. ’70

eonard J. Newman, M.D. ’70, and
Michael H. Gewitz, M.D., think alike.
This surely accounts for what they
have accomplished for their constituency—
the children of the seven-county lower
Hudson Valley, and areas in neighboring
Connecticut and New Jersey. First class
facilities and a team of specialists second to
none are the achievements of Dr. Newman,
chairman of the Department of Pediatrics at
New York Medical College, and Dr. Gewitz,
vice chairman, and physician-in-chief and
director of the Maria Fareri Children’s
Hospital at Westchester Medical Center.

When you speak to them separately they
often verbalize as one, answering questions
nearly in identical words and speaking in
Michael H. Gewitz, M.D.
oddly similar cadences. Over and over, as if it
were the first commandment of evolution, they talk about taking care
of children, and the listener is left comfortable and satisfied. They both
continue to see patients, new and old, who keep their doctoring skills
from getting rusty. What leaves the biggest impression, though, is how

seamlessly they work together, chalking up one success after another
with each endeavor.
Leonard Newman has a CV that should be enshrined for viewing by
every applicant interviewed at New York Medical College. With the
exception of an internship at University Hospital of San Diego County
in California, and a fellowship in pediatric gastroenterology and nutrition at Albert Einstein College of Medicine in the Bronx, Dr. Newman
has spent every year of his professional life with the College—both
on the Valhalla campus and in New York City, when the College was
located at Flower and Fifth Avenue Hospitals. Asking what else there
is to accomplish elicits a heartfelt answer that evinces something he
can’t control: “Just leave us alone. No more cutbacks.” In this time of
unprecedented economic stress then, is it perhaps time to get out?
“I enjoy what I’m doing, but I might retire in three, four or five years,”
he says, with a near dead-pan that implies he isn’t serious about
stepping down at all.
Future is now
Dr. Newman knows what it takes to make a department run smoothly,
but the economic treadmill is a tough opponent. “No one is desperate to come to this part of the country, and the cutbacks make it
worse,” he says. “To get good people you need to recruit, and there is a
process. My wish is to keep the good people I have, and to keep them
satisfied. We are also trying to increase research in the department,
and programs are impacted when dollars are cut. It’s a problem all over
the country, especially in pediatrics.
“There was a time when we were worried about survival. It’s not like
that now, even though things are tough all over. But I don’t think the
hospital ever had the so-called good old days,” he continues. “There
was always turmoil of one kind or another. Times would get better
but then turn dicey when government cuts removed support.
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Still, we are optimistic. The opening of the children’s hospital satisfied
a big chunk of my wish list. What I’d really like to see is cooperation
between Westchester Medical Center, the College and the
Department of Pediatrics. I’m not sure it ever existed before.”

good overview of what is needed to run a huge program. That teamwork is essential. You can’t be chairman and also run a major hospital.”

Dr. Newman prefers to leave discussion of the Maria Fareri
Children’s Hospital at Westchester Medical Center to its director,
Dr. Michael Gewitz. He credits Karl P. Adler, M.D., now president
of the College, with the foresight of putting them in the right jobs:
“When Karl was dean [School of Medicine, 1987 to 1994], in a
moment of genius he made me chair of the department and Mike
director at the hospital. Mike and I have worked together from the
beginning and have always had a close relationship. He enjoys the
more administrative and political sides, but he is also a first rate academician and teacher. I’m more interested in practice management
and faculty development, and also in strong academics. We have
found our niche, but at the core we are both caring doctors with a

A big what-if in Dr. Newman’s past offers a glimpse into his gut instincts:
his high school guidance counselor told him he would make a good
social worker. “No, I really want to be a doctor,” he insisted. Accepted to
several medical schools but preferring to be in Manhattan, he chose the
College because “the people I met from Admissions were wonderful.”
And so, after an undergraduate degree from Rutgers University in his
home state of New Jersey, Dr. Newman began his love affair with
New York Medical College. Helping him to decide on pediatrics and
gastroenterology were two “inspiring teachers in my junior year
rotation,” he says: the late Edward Wasserman, M.D. ’46, former chair
of the department, and George D. Rook, M.D. , former professor of
pediatrics. For his fellowship, Albert Einstein beckoned: the renowned
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Inspiring teachers

The making of a hospital

“The goal of the
Department of
Pediatrics is still the
same: to be a resource
for children in the
seven counties and
beyond. Mike Gewitz
and I have the same
desire to provide this
excellent care and by
all measures, I think
we have succeeded.”
- Leonard Newman, M.D. ’70

Murray Davidson, M.D., was there. “He could be called the
father of pediatric gastroenterology,” says Dr. Newman.
“Davidson developed treatments for ulcerative colitis,
Crohn’s disease and celiac disease.”
Dr. Newman delights in taking credit for marketing the
hospital practice to local pediatricians, who initially feared
competition “from Valhalla” when the College moved up
from New York City. As he continued to recruit stellar chiefs
for sections that range from endocrinology to neonatology
to immunology and infectious diseases, the word began to
circulate: send your really sick children to Westchester. “The
goal of the Department of Pediatrics is still the same: to be
a resource for children in the seven counties and beyond,”
says Dr. Newman. “Mike Gewitz and I have the same desire
to provide this excellent care and by all measures, I think we
have succeeded.”

They spend most of their work days supervising 200 full-time faculty
pediatricians, 100 of them on campus. Since 2004 the primary location
is the Maria Fareri Children’s Hospital, a stunning architectural showpiece
filled with stuff that kids love, like a real locomotive, a wall of furnished
dollhouses, a baseball museum and a gigantic aquarium to explore. Oh,
and it also boasts state of the art technology and some of the best doctors
in the Hudson Valley, making it the leading choice for the care of children
and their parents who can stay overnight with them if they desire.
Built on such a grand scale, it is hard to believe the space is already too
small—by 30 percent, Dr. Gewitz advises. “It is frequently over capacity,
something we predicted during the planning. But the consultants we were
using then voted us down,” he says, adding slyly, “The new consultants
agree with us.” If it is unseemly to call something a success that is built
because of the needs of sick children, one should remember that it was
the death of one young girl that provided the impetus in the first place.

“Lenny and I are pretty symbiotic.
Our partnership has allowed us
to make the most of our talents.”
– Michael Gewitz, M.D.

After their daughter Maria died in 1995 at Westchester Medical Center,
where she was moved when a community hospital was unable to diagnose her deadly condition as rabies, John and Brenda Fareri offered the
motivation and momentum to create one of the first children’s hospitals
designed solely for children and families, and only one of four freestanding
acute care children’s hospitals in the state. “The Fareris became involved
because they felt the top notch medical care we provided should be
delivered in a better environment, having experienced the deficiencies
of the original building and the absence of facilities for families to stay,”
says Dr. Gewitz.
“Sometimes around here we have a tendency to snatch defeat from the
jaws of victory. My colleagues and I, along with the key support from the
Fareris and families throughout the region, worked very hard to see this
project through. In fact, writing a book about the trials and tribulations of
the academic health center that is Westchester Medical Center/New York
Medical College is something I threaten to do in retirement, along with
playing with my grandchildren and still contributing to the education of
future doctors.”
Full time job plus
Michael Gewitz has helped to take pediatric cardiology around the
world—as far as El Salvador and Ukraine. As professor and vice
chairman of the College department, and chief of pediatric cardiology
and physician-in-chief/executive director of the hospital, he has not had
time lately for such things as travel. Even his weekend social life revolves
around honoring colleagues and other fundraising events that come with
the territory. He qualifies for the best and that is what he gives; starting
with his training, it’s the way he’s lived his life.
Brooklyn-born Mike Gewitz received his undergraduate degree from Yale
in 1970, and his medical degree from Hahnemann Medical College in
Philadelphia. Internship and residency were at Children’s Hospital of
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Philadelphia (CHOP), the oldest facility of its
kind in America. He finished residency as a
CHOP representative to The Hospital for Sick
Children in London, the oldest one anywhere.
Then he returned to Yale for an NIH sponsored
fellowship in pediatric cardiology. In 1979 Dr.
Gewitz began his attending career at CHOP
and the University of Pennsylvania School of
Medicine. He left as an assistant professor
after five years to join the College as associate professor, and was appointed chief of the
section of pediatric cardiology at the medical
center. In 1989 he was promoted to full
professor, and three years later became vice
chairman of the Department of Pediatrics.
Love of teaching
There are 49 residents and 18 fellows learning
the trade this year, making Westchester Medical
Center a top graduate program in pediatrics,
says Dr. Gewitz. Both he and Dr. Newman
interact with them and the College medical
students regularly. “Lenny and I built a team that
spans the scope of complex medical specialties
and includes a great primary care group and
child advocacy program. We have an unbelievable combination of people and programs, held
together by an entrepreneurial approach within
an academic medical center. And we did it in
the shadow of the New York City giants. Lenny
and I are pretty symbiotic. Our partnership has
allowed us to make the most of our talents.”
Those include patience and perseverance.
“Working with Lenny means every day is a new
day. He throws lots of balls into the air and then
gets out of the way. Lenny has a great capacity
for thinking outside the box. Sometimes the
unpredictability of it is challenging. It is always
interesting,” says Dr. Gewitz.
When Dr. Newman does retire, what will that
do to Gewitz’s own plans for the future? There
is still a lot to be accomplished,” he says. “I’m
not ready to go yet. We need to expand the
hospital, expand our research programs, and
enhance the total capacity of surgical specialties. And all the time to continue our mission as
advocates to upgrade children’s health care in
the region.”
Will that be enough? The good doctor reveals
he has taken on the chair-elect position of
the Council of Cardiovascular Diseases of the
Young, one of the 13 scientific councils of the
American Heart Association. “It’s a four-year
commitment,” he reveals. “I guess I just don’t
know how to get out of the way.”p

16

Spring/Summer 2009

As we approach the College’s 150th
anniversary, we invite you to join the
many benefactors who are working
to maintain our tradition of excellence
in the 21st century by investing in
the Annual Fund.

✁

Support
New York
Medical
College

READER
SURVEY

Please fill out this reader survey and return in the
envelope provided. If you wish to enclose a donation,
it will be gratefully appreciated.
1. Why do you read Chironian? (Rank in order of
importance)
______ News about alumni
______ News about the College, its activities and progress
______ News about students, faculty, leadership
______ Trends in research and medical education

Expand Educational Opportunities – Each year,
our students assume an increasingly heavy financial
burden as the cost of a first-rate health sciences
education skyrockets.

______ the “State of the University”

Your gift will strengthen our tradition of reducing financial
n 
barriers for many talented and deserving students.

______Read it cover to cover

Enhance Academic Leadership – New York Medical
College boasts some of the brightest minds working in
health sciences education and research today.

______Read only what interests me

______ Other ____________________________
2. How much of each issue do you read?

______Read or skim about half the articles

______Read only about people I know

Your gift will provide the resources needed to continue
n 
to develop this stellar academic team.

______Don’t read it

Invest in Campus Infrastructure – The resounding
success of the Medical Education Center and recently
renovated Basic Sciences Building lobby demonstrates
the key role that beautiful and innovative facilities play in
creating a desirable academic environment.

3. Please rate how much you agree or disagree with the
following statements:

Your gift will help to improve and maintain campus
n 
facilities at a competitive level.
Transform Medical Education – Having access to
new technologies like the successful and popular digital
curriculum database and multi-specialty patient
simulators is essential for our students and faculty.
Your gift will prepare tomorrow’s healthcare professionals
n 
for the challenges and opportunities of 21st century
medicine.
Please make a gift today. Your support will have an
extraordinary impact on the College’s future.

Strongly
Neutral		
Disagree				
1

2

3

Strongly
Agree
4

5

The articles are interesting and informative______
The layout and design make it easy to read ______
The magazine keeps me up to date on alumni ______
The magazine keeps me informed about College
current events and the state of the university _______
The magazine is one way to learn about trends in
research and medical education _______
The articles provide a good balance of the technical
and the personal ______
(continued on reverse)
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SURVEY (continued from other side)
4. Please rank from 1 to 5 which sections of Chironian
interest you the most (1= most interest, 5= least interest)
______Research articles		

______University news

______Personality profiles

______Student features

______Alumni news		
______Milestones
					
(class notes)
5. On a scale of 1 to 5 (1= very well, 5= not well at all) rank
each of the following for how well Chironian keeps you
informed about:
______News about alumni
______News about the College, its activities and
accomplishments
______News about students, faculty, or leadership
______Trends in research and medical education
______the “state of the university”
______Other _____________________________________
6. What other topics or features would you like to see in
Chironian?
_________________________________________________
_________________________________________________
_________________________________________________
7. Which best describes your relationship to New York
Medical College?
__Alumni (Circle: Medicine, Basic Sciences, Public Health)
__Faculty (Circle: Full-time, Part-Time, Voluntary)
__Student (Circle: Medicine, Basic Sciences, Public Health)
__Staff
__Campus or facility (Circle: Main, WMC, SVCMC, Met, Other)
8. Preferred method of keeping in touch:
__Mail
__Email
__Social network (Facebook, LinkedIn)
__Other __________________
9. If you could change one thing about Chironian, what would it be?
_________________________________________________
_________________________________________________
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Students
Alberto Distefano

A Taste of
Real World
Medicine

Narissa Small

Three medical students tell how summer research
fellowships changed their views of medicine—
and of themselves as future physicians.

Paul Nestadt

By Thomas Orton

A

ny medical school curriculum will immerse students for their first two years in a veritable tidal wave of
information—paper and electronic, lecture and small group study, journals and labs. But getting out of the
classroom and library to work with a top-flight team of researchers, or to accompany a surgeon on patient
rounds—these are realities that most medical students can hardly wait to experience.
At New York Medical College, there’s a way to get this training in a hurry: student summer research fellowships.
Each year, some 50 first- and second-year medical students are awarded fellowships by the Student Research
Fellowship Program. More than 130 faculty-mentored projects, each lasting 6-8 weeks in the summer, cover a
broad spectrum of disciplines. On one level the fellowships give extra practice in fundamental skills, such as writing
patient status summaries or mounting slides. Spending a summer immersed in a project, whether in a clinical setting
or a basic science lab, can help clarify a student’s career goals and give a welcome jolt of inspiration for the
remaining years of study.

Photo by John Vechiolla

Still, the real benefit of a fellowship is the exposure to a field of inquiry, a branch of medicine or an affinity for the
bench—something totally new or unexpected that ignites a passion they never knew was there. This is how it happened to three medical students last summer, during fellowships they undertook following their first year of study.
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From Westchester to
West Indies

A knack
for compassion

Psychiatry
summer

Alberto Distefano

Narissa Small

Paul Nestadt

As if his neurosurgery fellowship at Westchester
Medical Center (WMC) wasn’t enough of a
new experience, Alberto Distefano, 24, left his
fellowship briefly to go on a church-sponsored
charitable mission in the Dominican Republic.
There he worked with a medical team in
La Romana, helping to build a hospital and
teaching the children of sugar workers on
the plantations.

Narissa Small, 25, has always been fascinated by
how people interact. As an undergraduate she
majored in sociology. “Nothing medicine-related
at all,” she says with a laugh. “But I was really
intrigued by theories about why humans get
along or don’t get along.”

Psychiatry has always been of keen interest to
Paul Nestadt. Accordingly, he followed that
inclination when applying for a psychiatry fellowship. A bonus: it was being mentored by Spencer
Eth, M.D., professor of psychiatry, who achieved
wide renown for his work with 9/11 survivors
and post traumatic stress disorder (PTSD), and
one of Nestadt’s heroes.

Back in the states, Distefano resumed his
neurosurgery fellowship. In addition to his
full schedule of second-year classes, he began
observing brain surgeries at least three days a
week. “The surgeons let us literally look over
their shoulders,” he says. “When they were
using microscopes, they’d show us what they
were doing on a TV monitor.”
He was particularly impressed by a procedure
involving deep brain stimulation of a conscious
Parkinson’s patient. The surgeon probed the
man’s brain with electrodes, then asked him to
describe the sensations. After observing in the
OR, he accompanied his mentor, Raj Murali,
M.D., professor and chairman of the Department of Neurosurgery, on post-op visits. It was
heartening to see the extent of some patients’
recovery and their gratitude. But, he adds, “it
was difficult to see patients who were very
sick and weren’t expecting a good outcome.”
Distefano came to medical school already
armed with some research experience. After
earning a B.S. in biological sciences degree
from the University of Connecticut, he spent
two years at Yale researching Type II diabetes.
While he thoroughly enjoyed the experience,
he now concludes, “Working in a hospital
makes things a whole lot more interesting.
It’s a lot more alive.” His summer clinical
experience impressed him enough to consider
a neurosurgery specialty, although he is also
contemplating a specialty in ophthalmology or
gastroenterology. And research may still be in
the picture. “When you’re doing research,” he
says, “you can see how it correlates to people.
But it’s not as direct as treating patients, where
the reward is extremely visible and direct.”

Small’s summer fellowship took her to Maria
Fareri Children’s Hospital at Westchester Medical
Center, where she worked in the Division of
Newborn Medicine, a subspecialty of pediatrics.
“I was attracted to neonatology because it’s
a fast-growing field. It’s also where you get to
treat the sickest newborns,” she says.
This wasn’t Small’s first exposure to the medical
center. The daughter of a nurse manager, she
volunteered in the hospital’s ambulatory care
unit during high school. After graduating from
New York University, she spent two years as a
fellow in the cardiovascular research laboratory
of former faculty researcher Piero Anversa, M.D.
Working with his team studying myocardial cells
in the repair of the heart, she decided her future
lay in attending medical school and earning her
place as a member of the Class of 2011.
Those years of exposure to both medicine
and research benefited her during the summer
fellowship. Rather than being overwhelmed
by the hospital’s hectic pace and the rigors of
working with extremely sick infants, Small found
herself thriving. After morning rounds, she would
follow the progress of certain patients, recording information needed for a research project
conducted by her mentor, Boriana Parvez, M.D.,
professor of pediatrics. The research focused
on necrotizing enterocolitis, a disorder in which
parts of an infant’s bowel tissue begin to die.
While the experience heightened her interest in doing more research, Small found great
satisfaction from her close contact with patients.
Working with doctors, she says, “gave me a
special sense of purpose. Being able to relate to
the families of sick infants was very intense and
moving.” Perhaps echoing lessons learned from
that early interest in human interaction, she
concludes, “Working with people in a hospital
setting teaches you a lot about compassion.”

At Saint Vincent’s Hospital Manhattan, a College
affiliate, Nestadt accompanied Dr. Eth’s team on
daily consulting liaison rounds, evaluating patients
for conditions like delirium and psychosis. “I’d check
their charts, make notes and report to the residents,” Nestadt recalls. “I learned psychiatry’s role
in the treatment of general hospital inpatients.”
In the afternoons he participated in lab research
projects at Mount Sinai Medical Center. He also
worked on several papers, presenting one at the
College’s 2009 Medical Student Research Forum,
where he placed second. Once a week, Nestadt
attended mental health court where psychiatric
inpatients sued for their release from the hospital. Nestadt recalls, “At first the judge and lawyers
seemed so cold and procedural, but they only
want what’s best for the patients.”
Though always drawn to research, Nestadt
admits that “med school was never really on
my radar when I was younger.” After completing
undergraduate work in neuroscience at Brandeis
University, Nestadt, who is 27, returned to his
hometown of Baltimore to help start a charter
high school. Eventually he made his way back
to medicine, working several years with a
psychiatric research team using magnetic resonance spectroscopy to locate biomarkers for
depression and PTSD. After that, medical school
started to make the most sense to him.
While his fellowship reaffirmed his love of
research, his work at Saint Vincent’s considerably
widened his opportunities. “The clinical side of
medicine has always captivated me a lot more
than the research side,” he says. “But eventually I’d like to do a combination of teaching,
research and patient care.” Matter of fact, that
trio of interests happens to match the mission
of New York Medical College. p
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Finding
Purpose in
Soldiers’
Eyes
A pediatrician
and a soldier,
“Dr. Charlie” brings
empathy, lollipops and
healing to sick children
and young men at war.

Dr. Graboys was profiled in
Chironian in 2000 when he was,
as he describes it, “on top of
the world in every way.”

Col. Charles Garbarino, M.D. ’78
By Andrea Kott, M.P.H.

W

hat keeps Col. Charles Garbarino, M.D. ’78, going
back to war? It is the memory of his beloved Uncle
Willy, who fought in the Battle of the Bulge, and
all the children he has cared for in his 30 years as a
pediatrician. It is the child within each wounded soldier he treats,
and what he sees in the eyes of those soldiers.
“These soldiers out there are still young,” says Dr. Garbarino, who
has served two tours of duty in Iraq and this summer will deploy
to Afghanistan. “Even the older ones need their hands held. No
matter what their age, when I hear their stories… I can feel how
they’re missing their families back home.” He adds fervently, “We
must tell their stories. We must tell people what war is all about.”
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And so he has self-published Pediatrician Soldier, a collection
of essays about his tours of duty in Iraq and Kuwait. Compiled
from his emails and diary entries, the book tells how Dr.
Garbarino left a successful medical practice for a combat
zone. It provides graphic, eyewitness accounts of war and its
aftermath, and sings praise to Dr. Garbarino’s “true heroes,” the
soldiers who do and do not come home and their loved ones,
including his wife Lydia, who are left waiting. All proceeds from
the book’s sales will benefit Our Military Kids, an organization
that funds enrichment activities and tutoring for children of
deployed and severely injured National Guard and Military
Reserve personnel.

- Charles Gabarino, M.D. ’78
“People don’t know what these soldiers are going through,” Dr.
Garbarino says. “Here you have your life and I have my life, and
right now there’s a soldier who’s coming home in a box or who
is mentally scarred for life.”
In an entry titled, “Guarding a Road,” Dr. Garbarino writes about
the risks he encountered every day, as a soldier: How to hold up
your hand and tell a vehicle to stop while others have weapons
pointed at them. Good luck. My hand in the air is going to stop
a moving vehicle loaded with bombs and insurgents who don’t
care, who will not stop and who will shoot me as they go by—but
with my hand still in the air asking them to stop.
Real heroes
In another entry, “One Soldier—Never To Return,” he describes
the anguish of reviewing a dead soldier’s medical records: I
held in my hands this soldier’s medical record. Here was his
name and his identification. But I knew nothing of this brave
individual who gave his life. Then I thought about this soldier’s
family. Was he married, did he have kids? How was his family
coping with his loss? So many questions—and yet I could not even
see his face. All I knew [of him] was a name and number. All I
could do was cry.
Dr. Garbarino pays special homage to individuals like the late
Captain John J. McKenna, who was killed by sniper fire while
leading a mission. His book also tells the story of Sgt. Daniel
Tallouzi, the victim of a mortar attack who died in February
2009 after living for more than two years in an “eyes open”
coma. “The real heroes are in my book,” he says. “I’m just a
simple pediatrician and a soldier.” Yet little about Dr. Garbarino
is simple.
Born and raised in the Bensonhurst section of Brooklyn, he
grew up, in his words, “lower middle class,” an only child from a
close-knit family. Outgoing and athletic, an Eagle Scout, a tennis
player and a member of many clubs, he attended St. Francis
College on a full scholarship. “First I wanted to be a missionary
priest, and then I got to know girls better,” he says, chuckling.
Then he thought seriously about the people he wanted around
him and the kind of work that would allow him the freedom to
be the pediatrician he always wanted to be—one who delights
children with a clown nose, propeller beanie, Mickey Mouse
shirt and lollipops, the one affectionately known as “Dr. Charlie.”

“I always wanted to be a pediatrician and there was only one
place I wanted to work: Flower and Fifth Avenue Hospitals,” he
says of the College’s former home in Manhattan, now Collegeaffiliated Terence Cardinal Cooke Health Care Center. Inspired
by two pediatrics professors, the late Harry Dweck, M.D., and
Marvin Green, M.D., neonatologists who were then teaching at
affiliated Metropolitan Hospital Center, Dr. Garbarino pursued a
neonatal fellowship at SUNY Stony Brook, where he also became a
pediatric emergency physician and a pediatric developmentalist. He
practiced neonatology on Long Island and later in Lynchburg, Va.,
but felt that something was missing from his life. The wanderlust
turned him into a medical officer in the U.S. Army with the hope
of seeing the world.
Mickey and Minnie
Soon after enlisting, he met and married Lydia Fernandez, an
emergency room nurse and his wife of 23 years. A woman after
his own heart, Lydia matched her husband’s wedding attire with
a Minnie Mouse sweatshirt (he wore Mickey), dungarees and
sneakers. In 1987, the couple moved to Germany, where they
lived and traveled around for the next three years.
Although initially headed for Operation Desert Storm, the war’s
brevity brought Dr. Garbarino and Lydia back to the United States
and to Livingston, N.J., where he now shares a pediatric practice
with Deborah Coy, M.D. He is also an associate in the neonatal
intensive care unit at St. Barnabus Medical Center in Livingston,
where he teaches several courses in life support.
In 2003, Dr. Garbarino became the first New Jersey Army National
Guard physician deployed in support of Operation Iraqi Freedom.
Convinced he wouldn’t be coming back, he wrote a letter to Lydia
asking that she not mourn his death. “I want you to celebrate my
life, my dungarees, my t-shirt with Mickey, my sneakers,” he recalls
writing. As he anticipates his next mission, the one that will take
him to war-torn Afghanistan, he says he is afraid, but not of dying.
“I look at all these soldiers with missing limbs,” he says. “I’m not
afraid to die but I’m afraid to come back in pieces.”
He goes, nevertheless, to appease the soldier and pediatrician
inside him, for the soldiers who are just “big kids” and need his
humor, empathy, love and lollipops to make them smile, and for
children everywhere. “Kids are the future,” Dr. Garbarino says.
“You need to have a world where kids can grow up.” p

Photo courtesy of Dr. C. Garbarino

“No matter what their age,
when I hear their stories…
I can feel how they’re missing
their families back home.”

“Dr. Charlie” Garbarino and his wife Lydia
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Survival of the Fittest
How one dynamic woman
plans to change the world,
one stair-stepper at a time.

E

By Lynda McDaniel

lizabeth DeLuca, M.P.H. ’07,
grew up enjoying the
carbohydrate-rich foods of
her native Cuba. Then one
day, at an age when other kids are
still feeding quarters into snack
machines, she made a conscious
decision to change her diet. Today,
she’s one of the most sought-after
fitness instructors in the Northeast
and owner of FitWell Group, a
fitness consulting and management
company based in Stamford, Conn.
Sounds like quite a turnaround, but
for this human dynamo, it’s just
business as usual.
“My passion has been health and
fitness since I was 12 years old,”
DeLuca says. “As an overweight
child, I couldn’t compete or participate effectively in sports, so I started to exercise and eat healthier
foods so I could be more competitive in school sports. Later, when
I realized that I wanted to help others create healthy lifestyles, I
decided I needed an advanced degree in public health.”
In the late 1990s, DeLuca was taking classes in what was then
known as the Graduate School of Health Sciences, but had not yet
decided on a concentration. At one point the school offered a career
workshop, and there she had an epiphany that clarified her vision
for the future. When the instructor asked, “What would you do right
now if you could start doing it today?” DeLuca didn’t hesitate.
“That’s when I knew I wanted to run a fitness consulting company.
One that could create high-quality nutrition and exercise programs
geared to corporations,” she says.
For most of us, that vision would take a few years to bring about.
Not DeLuca. Imbued with her father’s entrepreneurial spirit, she
incorporated FitWell Group within nine months of that workshop.
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“My family moved to America right after Castro, in the late 1960s
when I was just a baby,” DeLuca says. “I always remember my
parents saying that America is the best place to live, work and
prosper. And I carry that spirit with me.”
Just two years later, she has 22 employees and a roster of consultants, serving clients such as Legg Mason, Elizabeth Arden and
Citigroup as well as other corporations, country clubs, institutions
and private clients in Fairfield and Westchester counties.
Never a dull moment
With the business up and running, it would seem like a good time
for DeLuca to enjoy the fruits of her labors. Not yet. Last September she enrolled in the College’s two-year doctor of public health
(Dr.P.H.) program in order to take her dream to the next level.
“Once I started working, I knew I wanted to do more,” she says.
“The Dr.P.H. at New York Medical College is the only program in
the Northeast that pays so much attention to the social determinants
of health. Economic and social conditions are crucial to the health
of everyone, and we all need to be more aware of their impact.
This degree program, especially now that health care is changing,
is worth all the time and investment. It continues to inspire me and
grow my business.”
DeLuca learned a lot about the positive impact of exercise in the
workplace from preparing a study for her master’s thesis, “The
Relationship Between Body Mass Index (BMI) and Health-Related
Quality of Life Among Participants in a Worksite Fitness Center.”
In March, she and a fellow doctoral student in the School of Public
Health, Ihsaam Alim, won first place for their poster presentation
at a conference on obesity sponsored by the Bronx County Medical
Society.
“The existing literature shows that exercise in the workplace not
only breaks the tedium of work, it also reduces absenteeism and
healthcare costs. Plus it increases morale by helping people feel
good about themselves and their workplace,” she says. “My study
showed that employees who participate in a FitWell program report
more healthy days than those who don’t.”
Back on the job, DeLuca is involved with everything from conceptual
site designs, master planning and programming to instruction,
management, and marketing. She also develops dynamic transitional programs to help ease reluctant employees into safe and effective
practices that will help them achieve good health.
Her busy schedule includes teaching classes at local fitness centers
as well as at FitWell Group corporate locations. Occasionally she’s

invited to model for fitness magazines
and videos. And she visits with clients to
determine special needs, such as coordinating a health fair or a popular event
she has dubbed Corporate Spa Day.
“We host Pilates and yoga classes, chair
massages, blood-pressure screenings,
body-fat fitness analyses, and mininutritional consultations,” DeLuca
explains. “A lot of people sign up for
these company-sponsored events.
We promote it as a much healthier
alternative to the holiday party.”
Heart in her work
Even with her busy schedule, DeLuca
finds time to volunteer for the local
Young Women’s League, helping with
community and children’s issues. She’s
also involved in the Boys and Girls Club
and is a sponsor of an annual 5K run.
So it’s hard to imagine that she has much
free time for herself and her husband,
Louis, who is president of AIM Health
Plans in New York City. But this holistic
teacher knows better than to neglect her
own well being.
“We live in a beautiful area with wooded
and open natural spaces where I take long
walks,” she says. “I love taking Big Blue,
my 7-year-old, 150-pound Mastiff with me.
That’s challenging—Mastiffs were bred as
guard dogs during the Roman Empire, so
walking is not their thing.”
As her career vision grows, DeLuca
isn’t content to confine her goals to the
corporate setting. She’s ready to take
on the nation and the world. While she
values her impact on companies and
their employees, she wants to contribute
to improving the health of the entire
population.
“I hope that by helping employees
become healthier, they’ll go home
and share this information with their
families,” she says. “But I want to help
as many people as possible make good
health a priority, creating a lifestyle with
better eating and exercise habits. My
doctorate will enable me to better understand healthcare policy so that I can
have a greater impact. My ultimate goal
is to partner with the new presidential
administration. Once the White House
meets FitWell Group, together we can
make America a healthier place.”p
Continued on page 34

Elizabeth DeLuca, M.P.H. ’07
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Perpetual
Learner

By L.A. McKeown

Jay S. Pattumudi, J.D., M.S. ’98

An interest in science and legal rights led this former
basic scientist from the laboratory to the legal field,
where patent law and researchers struggle to coexist.

H

ave you ever seen a really cool new invention
and wondered how in the world you patent
something like that? Well, if you’ve got questions,
Jay Pattumudi, J.D., M.S. ’98, is your go-to guy.
“It’s true. I love what I do,” he says with a laugh.
As a patent attorney, Pattumudi is part of the behindthe-scenes work that takes an invention or device from
the inventor’s hands to the public. He first became
curious about this specialized field of law while studying
biochemistry and molecular biology in the Graduate
School of Basic Medical Sciences. One of his favorite
professors in the department was Ira Schwartz, Ph.D.,
now professor and chairman of the Department of
Microbiology and Immunology, who he says “conveyed
an infectious enthusiasm for molecular biology.” While
Pattumudi always enjoyed science and liked to write, he
also sensed that life as a researcher wasn’t for him. He
soon began to see a problem that few researchers think
about, or may even be aware of, until after they begin
publishing their research.
“Some of the aims of patent law may be in conflict with
how researchers operate,” Pattumudi says. “For example,
under U.S. patent law, you are precluded from a right
to a patent if you have published a paper on the same
invention more than one year prior to filing the patent
application.”
He continues, “It made me realize that faculty and
graduate students at research universities should be
educated about the innate conflict between what
operates in patent law and what operates in research,”
Pattumudi says. “By their very nature, researchers are
in the business of sharing knowledge and are thus very
eager to share such information.” Conversely, patent law
aims to provide exclusive rights to the person seeking
the patent and to exclude others from violating those
rights. Someone like Jay Pattumudi, with his first-hand
experience in the world of academic research, can help
scientists and inventors navigate these complexities,
resulting in greater protection of their rights.

patent searches. I just wanted to get a feel for patent
law so I could be sure it was the right career for
me,” Pattumudi says.
While attending the University of Wisconsin Law
School, he worked as a law clerk for a Wisconsin
law firm and several government agencies,
including the U.S. Department of Energy, before
receiving his law degree in 2002. Eventually he
moved to Tampa to take a position as an associate
at Fowler White Boggs Banker, one of the oldest
and largest law firms in the state. It was there that
he experienced first-hand the kind of problems
researchers can face if they are unfamiliar with
patent law.
He elaborates: “Some academic researchers are
unaware that their own actions can jeopardize
their patent rights. For example, European patent
law, even stricter than the U.S., generally forbids a
researcher from filing a patent application from the
moment he or she publishes a research paper on
that subject, according to the Absolute Novelty Bar.”
Depending on the country, there may be limited
exceptions, serving only to further complicate the
matter and making the expertise of someone like
Jay Pattumudi all the more valuable.
Always learning

Taking a different path

A science or engineering background is a
requirement for all patent attorneys and a keen
interest in technology is important too, says
Pattumudi, who considers himself a perpetual
learner. While some patent attorneys are solely
focused in one area, such as biotechnology or
pharmaceuticals, Pattumudi has worked in many
technical fields and most areas of patent law except
litigation. Having a B.S. in biological sciences from
Fordham University, in addition to his master’s from
New York Medical College, has boosted his ability
to assimilate different research concepts. His fluency
in these areas allows him to assist clients in taking
their ideas from experimentation to real-world use.

Intrigued by the intricacies of patent law and how they
relate to the research community, Pattumudi changed his
career path after getting his master’s degree. He went to
work as a patent clerk for a small law firm in New York
City that prepared patent and trademark applications for
research universities, corporate clients, small chemical
companies and biotechnology firms. “I assisted the
patent attorneys with writing applications and doing

“I keep up on certain things that I was interested
in while I was in graduate school, such as
adenoviral vectors in gene therapy,” Pattumudi
says. “It’s interesting to me to see how that field
is progressing, and I can do that by keeping up
with whatever my clients are working on”—which
could be anything from biotechnology to aircraft
cabin technology. “I’m often required to learn what
(continued on page 29)
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Milestones
’06 and ’07

’00

Angel M. Garcia Otano,
M.D. ’06, and Dana M.
Delach, M.D. ’07, are married. Both are second-year
residents at the Williamsport
Hospital Family Medicine
Residency Program in
Williamsport, Pa.

Susan L. Morton-Pradham,
M.D. ’00, was inducted into
the Cambridge Who’s Who
Executive, Professional and
Entrepreneurial Registry. Dr.
Morton-Pradham is a physician
for Chloe Obstetrics and
Gynecology in Phoenix, Ariz.

Cathie T. Jones, M.D. ’03,
completed a fellowship in
pediatric anesthesiology at
Children’s Hospital in Boston.
Dr. Jones is now on staff at
Wilford Hall Medical Center
with the U.S. Air Force in San
Antonio, Tex., where she lives
with her husband Jared and
daughter Lillian.

’02
Roger R. Feo, M.D. ’02,
who graduated from the
Fifth Pathway Program at St.
Vincent’s Medical Center in
Bridgeport, Conn., completed
his general hospital family
medicine residency in 2008. Dr.
Feo practices at Berks Family
Care-Pottstown Memorial
Medical in Douglassville, Pa.

’01
Timothy McClung, M.S.,
M.P.H., ’01, is director of
quality improvement operations at Norwalk Hospital
(Conn.) He is a fellow of the
American College of Healthcare Executives.

School of
Public Health
Changes
Its Name
28
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the90s
Keith Berkowitz, M.D. ’95,
has co-authored The Stubborn
Fat Fix—Eat Right to Lose Weight
and Cure Metabolic Burnout
without Hunger or Exercise. Dr.
Goldstein is founder and medical director of the Center for
Balanced Health in New York
City and a former medical
director of the Atkins Center
for Complementary Medicine.
Andrew O. Chow, M.D. ’95,
is on the staff of Health First
in Fairfield, Conn., a facility “specializing in restoring,
maintaining and optimizing
the health of the Boomer
Generation.” Dr. Chow is a
Stanford-trained acupuncturist
and an active member of the
American Academy of Medical
Acupuncture.
Catherine G. Winkler,
M.P.H. ’95, has received her
doctorate from Yale and is a
nurse at Danbury Hospital
(Conn.), specializing in
cardiovascular disease.
Tess Kryspin, M.D. ’94, is a
certified physician executive
and director of ambulatory
practice for the Griffin Faculty
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’03

Mastering a craft,
Teaching a skill

David Goldenberg, M.D. ’82

R

By Andrea Kott, M.P.H.

emember shop? As in woodshop, where students made tie racks and coat
hooks? For some, it was a high school elective, respite from the drudge
of academics. For others like David Goldenberg, M.D. ’82, shop is a place
for solving problems, for learning focus and self-discipline—distant values in this
instant-gratification, multi-tasking age of cell-phones, Twitter and Facebook. “People
are enormously distracted, and kids today are horribly unfocused,” Dr. Goldenberg
says. What’s more, he adds, “People have forgotten how to make things.”
Dr. Goldenberg, a Connecticut-based plastic surgeon, has spent his life making
things. When he is not seeing patients in his Danbury office or making rounds as
chief of plastic surgery at Danbury Hospital, he is in his shop, casting a concrete
tabletop for plants, crafting knives or jewelry, building a telescope or making
surgical instruments. “I make anything, I don’t care what it is…every spare
minute,” he says. “The hobby is making.”

On June 1 the School of Public Health officially became the School of Health Sciences and Practice, and established the
Institute of Public Health. The school’s new name, leaders say, reflects a restructuring of the school’s mission, as well as a new
organizational scheme that offers more flexibility in planning degree programs and academic offerings. The School of Health
Sciences and Practice will comprise three accredited professional programs—in public health, speech-language pathology,
and physical therapy. The public health program will consist of three departments: Environmental Health Science, Epidemiology and Community Health, and Health Policy and Management. In addition, the new Institute of Public Health will expand
research and community outreach opportunities for students and faculty.

Long before he became a physician, Dr. Goldenberg was a machinist.
He ran metalworking equipment in high school and worked summers
in machine shops. He always planned to attend medical school and
knew plastic surgery was the specialty that suited him best. “I’m an
anatomic problem solver,” he says. “The satisfaction in plastic surgery
is being able to solve problems, getting a wound to close, repairing a
breast, restoring facial symmetry.”
While he finds medicine much more challenging than, say, fashioning an
arrowhead, he loves both because he appreciates shape and creativity.
“They go together very well,” he says. “Plastic surgery is really just
moving the tissues around, and what I do in the shop—knife making,
stone carving, building telescopes, blacksmithing—works from the same
concept of taking raw materials and shaping them into tools, devices
and machines.”
One of Dr. Goldenberg’s favorite projects is building telescopes. “I’m
always building the next biggest telescope,” he says. It isn’t the result
alone that Goldenberg prizes, however. It is the process and the
commitment and concentration it requires, qualities he says are not
promoted in today’s education system. This is why he insisted that each
of his three children, two of whom are now grown, build a telescope
for the science fair during high school. (His 16-year-old son recently
won first place in his school fair’s senior division.)
“You’ve got make kids focus,” Dr. Goldenberg says. “They’re so used to
multi-tasking that they can’t focus on a task and finish it.” He gave his
kids no choice. He told them, “God help you if you’re upstairs playing
a video game while I’m downstairs learning something. You’re going
to learn to use a table saw. You’re going to figure this out. There’s no
instant messaging, no talking to friends, no cell phones, no interruptions.
You do it until it’s done right.” And they did. “The first time you look at
a magnified vision of the moon through your own telescope…you’ve
got to see the smiles on their faces.”
Dr. Goldenberg is trying to cultivate self-reliance, not self-satisfaction.
“My wife tells my son to take the triple-A card with him in case he gets
a flat, and I say, ‘Teach him how to change a tire!’” he exclaims. “Society
makes it easy to be dependent on others. Whatever happened to
self-reliance and confidence in your own abilities?”
Even when things go wrong, there is plenty to learn from process and
outcomes, he says. “You can’t be afraid of failure. Too many people
don’t do woodworking or a craft because they can’t get past the initial
hump of failure. I fail all the time. I’m always making mistakes, but that’s
how I get better.”
At 53, Dr. Goldenberg is thinking about retirement. For years, he has
been writing a book about the history of surgical instruments. He also
has been planning to build a bigger, freestanding shop where he might
start building things to sell. “It doesn’t sit right with me that I have a
hobby that consumes but doesn’t produce any income,” he says, noting
the economic downturn. So he is considering selling hand-carved stone
planters for bonsai trees—unless he decides to dedicate himself to
making knives. Whatever he chooses, perhaps his “shop motto” will be
the phrase that he once used with his children: “Come with me, sit
by my side. I’ll teach you something that you can use for the rest of
your life.”p

Michael J.Traurig, M.D. ’91,
is a board certified phlebologist. Dr. Traurig treats diseases
of the veins. He lives in Greenville, S.C., with wife Nancy and
their two children, Julianna, 12,
and Alaynah, 10.

Practice Plan in Oxford, Conn.
Dr. Kryspin is board certified
in medical management.
Janet A. Stockheim, M.D.
’91, M.P.H. ’92, a clinical assistant professor of pediatrics
at NYMC, has written Nothing
but Newborn: A First-month
Primer for Parents, a book for
new mothers. Dr. Stockheim
lives with her family in Pleasantville, N.Y.

the80s
Alan H. Cohen, M.D. ’88,
works at MAP Pharmaceuticals
in Mountain View, Calif., where
he is Vice President of Clinical
Development and Medical
Affairs, Pulmonary.

Roger A. Gallup, M.D. ’91,
is a Colonel in the U.S. Army
and a III Corps Surgeon at Ft.
Hood, Tex., where he specializes in pulmonary/critical care.

Michael Fredericson, M.D.
’88, is professor of orthopedic
surgery at Stanford University
in Palo Alto, Calif. Dr. Fredericson’s research focuses on
the etiology, prevention and
treatment of overuse injuries;
patellofemoral pain, and stress

Mark J. Sterling, M.D. ’91,
who specializes in physical
medicine and rehabilitation, is
acting chairman in the division
of physical medicine and rehabilitation at St. Catherine of
Siena Hospital, Smithtown, N.Y.

Jay S. Pattumudi, J.D., M.S. ’98
(continued from page 26)

makes an invention unique,” Pattumudi says. “Just keeping
up with the law is challenging enough, but patent attorneys
have clients in many technological fields. I think I’m more
enriched by working in so many different areas.”
Late last year, Pattumudi and his wife Vaishnavi relocated
from Florida to New Jersey, where they have family nearby.
It’s also where he now works for Hoxie and Associates, LLC,
a firm that specializes in patents for biotechnology, medical
devices and pharmaceuticals. Though he is specialized in
one area of law, as a patent lawyer he considers himself a
generalist when it comes to technology.
He enjoys answering people’s questions about patents, even
if the answers are not always what the person wants to hear.
“When someone asks me to research an invention that they
think is patentable and it quickly becomes obvious that isn’t,
I tell them so. Sometimes it leads them to a different line
of thinking and they end up making a better product—you
know, the proverbial ‘better mousetrap.’ In the end, that
might be good for lots of people, and professionally, that’s
very fulfilling for me.”p
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Looking at Medicine
from the
Inside and Out
By Andrea Kott, M.P.H.

I

n work, as in life, it is the detours that have brought this alumnus home.
And home happens to be in Franktown, Virginia—not exactly where Stuart
Mackler, M.D. ’63, imagined he’d settle when he became an orthopedic
surgeon more than 40 years ago and headed to Boston for an internship and
residency at Beth Israel Hospital.
“It’s all because of New York Medical College,” Dr. Mackler says with unabashed
appreciation. It was there, as the fourth-year student president of the Phi Chi
medical fraternity, that he attended a lecture where Charles Bailey, M.D., spoke
about achieving satisfaction in medicine—professional, not monetary, satisfaction. Bailey was the world famous cardiovascular surgeon and then-chairman of
Beth Israel’s department of surgery.
“He recommended practicing in a rural area, because doctors were needed
there,” says Dr. Mackler, who retired in 2004. So, when he noticed an ad in a
medical journal for an orthopedic surgeon in Virginia, he applied. “Within six
months I was in Radford, a town of 15,000,” he says. “I was the first and only
orthopedic surgeon between Roanoke and Abingdon, Virginia.”

Stuart Mackler, M.D. ’63

fractures in athletes. In addition to serving as chief of the
physical medicine and rehabilitation outpatient clinics at
Stanford Hospital and Clinics,
he is team physician for Stanford sports teams and senior
associate editor of PM&R, the
journal of injury, function and
rehabilitation.
John Panella, Jr., M.A.,
M.P.H. ’88, is executive director of the Baltimore office of
SeniorBridge, an organization
that serves seniors and their
families by managing chronic
health care needs in the home
and other settings.
Joseph R. Wax, M.D. ’86,
returned to the Valhalla area
for the Seventh Annual Hudson Valley Regional Perinatal
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Forum in November 2008,
where he presented the latest
in female reproductive issues
following bariatric surgery.
Dr. Wax, professor of obstetrics and gynecology at the
University of Vermont School
of Medicine, Maine Medical
Center in Portland, specializes in high-risk obstetrics and
ultrasound.
David R. Charnock, M.D.
’84, practices otolaryngology at Mid-Vermont ENT in
Rutland. Dr. Charnock reports
that his oldest son graduates
college the same weekend
as his 25th NYMC reunion.
“Three more to go!”
Kevin C. Delahanty,
M.D. ’84, practices internal
medicine with a small group
in Salisbury, Mass. In 2006,

Photo by Linda Cicoira

It was 1976, and at the time there weren’t enough orthopedic surgeons to
populate the country. “I did get that satisfaction from being needed,” Dr.
Mackler says. “I got so busy I couldn’t take a vacation.”
It wasn’t just his professional practice that made Dr. Mackler feel content. It
was also living where he did. “There’s something about a smaller community,”
he says. “People know you by name when they run into you on the street. You
don’t get that in a big city.”
Dr. Mackler speaks modestly about his career achievements, but his CV reveals
another side of his life. He is currently a captain in the U.S. Public Health
Service Reserve, having served as a senior medical officer in Coast Guard

Dr. Delahanty retired after
26 years in the U.S. Navy and
relocated from Seattle, Wa., to
his current home in Newburyport, Mass. He married Joan
Elizabeth in 2001 and is the
father of two.
Andre Konski, M.D. ’84,
M.B.A., is chair of the department of radiation oncology
for the Wayne State University
School of Medicine and service
chief for radiation oncology
at the Barbara Ann Karmanos
Cancer Center in Detroit, Mich.
Miriam David, M.D. ’83,
married Richard B. Stranger on
March 29, 2009. She is director
of breast magnetic resonance
imaging in the department of
radiology at Jacobi Medical
Center in the Bronx.

Jill S. Hirsch, M.D. ’80,
reports that twin daughters
Allison and Jessica are in
their third year of a Ph.D
program in organic chemistry
at the University of California,
Berkeley.Youngest daughter
Larissa is a Drew University senior, also majoring in
organic chemistry. Dr. Hirsch’s
husband, Randolph Cohen,
M.D. ’80, is working in a large
multispecialty group in Middletown, N.Y.

the70s
Edward Scott Valentine,
M.D. ’78, is currently a
student in the Yale M.B.A.
for Executives: Leadership in
Healthcare program, Class
of 2010.

Squadron 3 in Vietnam from 1967-1968. He was awarded the Republic of
Vietnam Campaign Medal, Vietnam Service Medal, National Defense Service
Medal, the Sikorsky Air Rescue Award, as well as the 1990 Certificate of
Appreciation from the U.S. Department of Health and Human Services.

In Memoriam
Dawn P. Dawson, M.D. ’91,
died August 20, 2008. She was 45.

Elisabeth M.F. Shanks, M.D.
’46, died July 3, 2008.

Dr. Mackler is equally reserved when he talks about Virginia Governor
Timothy Kaine appointing him in 2008 to the Virginia Board of Medicine, an
unexpected and very timely honor. “It’s difficult for someone to just go cold
turkey and stop practicing medicine,” he says, “so it’s nice to keep your hand
in the field.”

John B. Montana, M.D. ’79,
died September 28, 2008. He
was 61.

Anthony Barbaccia, M.D. ’45,
died June 14, 2008.

Sitting on the board is a volunteer post to which Dr. Mackler devotes 15 to
20 days each month, regularly driving nearly three hours to Richmond for
hearings and reviewing approximately 12 cases. “It is a very interesting job,”
he says, describing the board’s oversight of physicians, osteopaths, interns,
residents, athletic trainers, physician assistants, acupuncturists, radiology
technicians and respiratory care practitioners. “We have more than 30,000
licenses,” he says.

R. Harold Parmalee, M.D. ’73,
died December 19, 2008.

It is eye-opening for any physician to be in the position of policing his peers,
especially in a climate that has grown increasingly litigious. “I’ve become aware
of how the system of law and the system of medicine are so intertwined,” Dr.
Mackler says.
He finds that, on balance, very few physicians come before boards for infractions. “There is the colleague who generally gives excellent care and makes
the occasional error of judgment—an omission, a missed diagnosis, a choice
made that doesn’t serve the patient well. It can happen to anyone, even the
best doctors in the country,” he says. “Perfection is not a part of medicine any
more than it is part of any other endeavor.” Yet, he says, “It’s a very important
thing that we police ourselves.”p

Dennis Roggemann, M.D.
‘76, is a cardiologist in Fort
Lauderdale, Fla., who devotes
his practice exclusively to
interpreting echocardiograms
via the internet. “My current
endeavor is to enable the
ultrasound of the heart to be
performed wherever a physician encounters a patient.”
Richard Kresch, M.D. ’71,
is president and chief executive officer of Ascend Health
Corp., which is renovating
and converting the old Cedar
Hills Hospital in Portland,
Ore., into a 36-bed psychiatric facility.
Ian Gale, M.D. ’70, is “still
practicing in Los Angeles,
after 32 years as a urologist.”

Dr. Gale and wife Lisa, a
flight attendant for American
Airlines, travel the world
extensively when they’re
not visiting their four grandchildren.

Julian F. DuBois, Jr., M.D. ’45,
died December 16, 2007. He
was 90.

Richard L. Brown, M.D. ’75,
died November 28, 2008. He
was 59.

James P. Angiulo, M.D. ’72,
J.D., died February 8, 2009. He
was 61.

Martin Nissel, M.D. ’44, died
January 28, 2009.
Robert Northway-Meyer,
M.D. ’44, died December 27,
2007.
Joseph F. Maiorano, M.D. ’43,
died July 23, 2008. He was 89.

Kwabena A. Addei, M.D. ’68,
died November 8, 2008.

Wallace T. McCaffrey, M.D.
’43, died October 29, 2008.

Melvin Gerber, M.D. ’64, died
April 7, 2008.

Jeanne S. Miller, M.D. ’43, died
January 3, 2009.

Arthur L. McGovern, M.D.
’62, died November 14, 2008. He
was 71.

Norman D. Stevens, M.D.
’43, died November 1, 2008. He
was 89.

Harry C. Smith, M.D. ’61, died
December 17, 2008. He was 74.

David I. Kraft, M.D. ’42, died
October 29, 2008.

Daniel M. Baer, M.D. ’57, died
April 5, 2009.
Benjamin Lamstein, M.D. ’57,
died October 29, 2007.

Robert C. Burnham, M.D. ’41,
died April 20, 2008.
Irving S. Behr, M.D. ’39, died
September 11, 2007.

Thomas P. Mathews, M.D.
’57, died November 19, 2008. He
was 77.
Lawrence A. Norton, M.D. ’56,
died May 13, 2009. He was 78.
Robert Dickinson, M.D. ’55,
died February 18, 2008.

Thomas G. Caceci, M.D. ’39,
died January 2, 2009. He was 94.
S.T. Coppola, M.D. ’39, died
June 27, 2008.
Charles J. Grubin, M.D. ’39,
died January 26, 2009.

John A. Schultz, M.D. ’55, died
March 25, 2009.

Nathan Arenson, M.D. ’37,
died April 2, 2008.

William R. Flynn, M.D. ’54,
died April 15, 2009.

the60s

Glenn S. Aggerup, M.D. ’53,
died March 10, 2009. He was 80.

Morris D. Rudick, M.D. ’32,
died December 4, 2008. He
was 99.

Robert J. Master, M.D. ’68,
received an award in March
2009 from the National
Committee for Quality Assurance for his leadership
in improving the quality of
care for vulnerable populations, especially the frail and
disabled.

Vernon E.Thomas, M.D. ’52,
died February 26, 2008.

Faculty

Edwin S. Stempler, M.D.
’61, is practicing orthopedics
(with a strong osteoporosis
program) part time in
Rancho Mirage, Calif.

Walter G. Elliot, M.D. ’51, died
September 12, 2008. He was 90.
Theodore S. Smith, M.D. ’51,
died October 29, 2008.
Albert M. Ondrako, M.D. ’49,
died June 16, 2008.
Nicholas Antoszyk, M.D.
’48, died November 3, 2008. He
was 87.
Arthur S. Kaplan, M.D. ’48,
died April 14, 2009.
Philip R. Gale, M.D. ’46, died
December 12, 2008.

Sheila Dotson Davis, M.D.,
professor of clinical radiology at
Westchester Medical Center, died
May 11, 2009.
Paul L. Chodosh, M.D., clinical
professor of otolaryngology at The
New York Eye and Ear Infirmary,
died September 6, 2008. He
was 84.
Mark H. Friedman, D.D.S.,
clinical associate professor of
dental medicine, of medicine, and
of cell biology and anatomy at
Westchester Medical Center, died
December 18, 2008.
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Alumni
Association
Board of
Governors

2009 Alumni Celebrations

Officers
President
Eileen (Lee) M. Dieck, M.D. ’86
President Elect
Mario F. Tagliagambe, Jr., M.D.’84
Vice President
Charles W. Episalla, M.D. ’88

1.

2.

3.

Treasurer
Stephen J. Nicholas, M.D. ’86
Archivist
Robert J. Furey, M.D. ’62
Elected Governors
John R. Addrizzo, M.D. ’64
Thomas D. Cerabona, M.D. ’82
John M. Cosgrove, M.D. ’83
Caroline A. Fierro, M.D. ’95
Joseph L. Giamelli, M.D. ’02
Jane N. Haher, M.D. ’67
Henry I. Saphier, M.D. ’61
George C. Shapiro, M.D. ’88

4.

5.

Faculty Governor
Leonard J. Newman, M.D. ’70
Past Presidents
Dennis J. Allendorf, M.D. ’70
Michael A. Antonelle, M.D. ’62
Saverio S. Bentivegna, M.D. ’50
Joseph F. Dursi, M.D. ’59
Louis E. Fierro, M.D. ’60

6.

7.

8.

Rita F. Girolamo, M.D. ’51*

Photos by John Vecchiolla, except 1, 2 (courtesy of Department of Medicine), 18, 20 (Photobureau), and 19 (Lisa Wanderman).

Cyrille H. Halkin, M.D. ’45*
Henry P. Leis, Jr., M.D. ’41*
David T. Mininberg, M.D. ’61

Research News

E. Edward Napp, M.D. ’33*

(continued from inside front cover)

Christopher F.X. Riegler, M.D. ’88

Paul Tartell, M.D. ’52*

physical and mental health are likely to worsen over time
and not necessarily expect that they will “bounce back,”
although declines in physical health are likely to be greater
than declines in mental health.

Member Emeritus

“Changes in Health-Related Quality of Life of Newly Diagnosed Cancer
Patients, Cancer Survivors and Controls,” Cancer, April 28, 2009.

Seymour Schlussel, M.D. ’51*
Lawrence B. Slobody, M.D. ’36*
Martin L. Stone, M.D. ’44

Philip A. Marraccini, M.D. ’50
Vice President,
Development and
Alumni Relations
Julie A. Kubaska, M.S.
Associate Director,
Alumni Relations
Tracey Clayworth

(*) Deceased
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Is there an alternative theory of evolution?
The animal kingdom, or Metazoa, arose from single-celled
ancestors in a few bursts of several million years between
500 and 600 million years ago. Embryos of all animal
groups—those containing insects, oysters, worms and
vertebrates like ourselves—use the same set of proteins
to produce their complex forms. According to Darwin’s
theory of natural selection, the major evolutionary steps
needed to generate animal forms would have required
much more genetic change and happened slowly.

Now a growing number of developmental biologists are
trying to understand how the transition from single-cell to
complex animal forms happened so abruptly. Stuart A.
Newman, Ph.D., professor of cell biology and anatomy,
has presented a new mechanism to explain these early
evolutionary steps, one that recognizes the role of the
material properties of cell aggregates in the generation
of biological form and pattern. Eons ago, changes in the
environment caused some ancient proteins already present
on the surfaces of single cells to clump the cells into multicellular clusters. Once these clusters existed, the products
of other previously existing genes began to mobilize physical
mechanisms and effects not relevant on the smaller spatial
scale of the individual cell to mediate the formation of
hollow, multilayered, segmented, appendage-bearing forms.
The result was a “pattern language” capable of generating
all body plans and organ forms of the animals.
“Dynamical patterning modules: a ‘pattern language’ for development and
evolution of multicellular form,” The International Journal of Developmental
Biology, in press, online at http://www.ijdb.ehu.es/web/paper.php?doi=10.1387/
ijdb.072481sn

1. At the Alpha Omega Alpha (AOA) induction ceremony on March 25, alumni initiate Peter A. Indelicato,
M.D. ’69, was congratulated by AOA chapter councilor
William H. Frishman, M.D., and Edmund F. LaGamma,
M.D. ’76.
2. AOA alumni initiate James E. Udelson, M.D. ’81, was
joined by AOA president Julie Krystal, Class of 2009,
and AOA junior member Allyson Chesebro, Class of
2010.
3. Laurence Friedman, M.D. ’59, and his wife Marilyn
Friedman attended his 50th reunion at the New York
Sheraton on May 16.
4. James Voskovitch, M.D. ’59, and Diane Bauer.
5. Members of the Class of 1959.

9.

10.

6. John Weg, M.D. ’59, and Mary Loretta Weg.
7. C
 ongratulating Mark Rosenblum, M.D. 69, winner of
an Alumni Medal of Honor, were Ralph A. O’Connell,
M.D., provost and dean; Eileen M. Dieck, ’86, Alumni
Association President; and Karl P. Adler, M.D., College
president and CEO.
8. C
 lass of 2009’s Jeffrey Eliason was selected to give
the student address at Commencement, while Angela
Fusaro, Student Senate president, received the Alumni
Endowed Scholarship.
9. Members of the Class of 1984.

11.

12.

10. Angela Fusaro, Class of ’09, was presented with the
Alumni Endowed Scholarship by Eileen M. Dieck, ’86,
Alumni Association President, and Karl P. Adler, M.D.,
NYMC President and CEO.

13.

11. Medal of Honor winner Mark Rosenblum, M.D. ’69,
and his wife Pam Rosenblum.
12. Joseph Dursi, M.D. ’59, associate dean for continuing
medical education, and Benjamin Sadock, M.D. ’59.
13. Michael Grenis, M.D. ’84, Medal of Honor recipient
Joseph Cervia M.D. ’84, and Mario Tagliabambe, M.D.
’84.
14. Herman Schaffer, M.D. ’59, Bernard Sonnenblick, M.D.
’59, and Lawrence Sheff, M.D. ’59.

14.

15. Honoree Joseph Cervia, M.D. ’84, was joined by Denise Blumberg, M.D., Carol Swift, and Steven Carolan,
M.D. ’84.

15.

16. Friends and spouses of the Class of 1984 were ready
with their cameras when the celebrants assembled
for a portrait.
17. Tedd Weisman, M.D. ’84, and Michael Grenis, M.D. ’84.
18. A very proud Peter Coffin, M.D. ’75, posed with son
Samuel Coffin, M.D. ’09, at Commencement in May.
19. At age 98 the oldest alumnus to attend the May
17 reunion luncheon, Sidney Wanderman, M.D. ’34,
stood before a portrait of Dr. Walter Gray Crump, his
former professor of surgery.

16.

20. Lawrence Sahler, M.D. ’88, and son Christopher Sahler,
M.D. ’09, at Commencement.

17.

18.

19.

20.
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